Hyperlipidemia

The FDA has granted breakthrough therapy designation to Arrowhead Pharmaceuticals’ plozasiran, coupled with diet, to decrease triglycerides in patients with familial chylomicronemia syndrome, according to a company release.

Women with vs. without intellectual and developmental disabilities have greater risks for stillbirth and other adverse obstetric, mental health and medical outcomes, according to findings published in JAMA Network Open.

Increased vitamin A intake may play a role in reducing depressive symptoms in patients with heart failure, according to a cross-sectional study published in ESC: Heart Failure.

According to published results, younger patients with high BMI, diabetes or hyperlipidemia may be at increased risk for shoulder adhesive capsulitis, also known as frozen shoulder.

Improving HDL function may improve outcomes after acute MI for patients with multivessel disease and high LDL, according to a subanalysis of the AEGIS II trial presented at the National Lipid Association Scientific Sessions.

ATLANTA — A remote, team-based approach with immediate initiation of necessary medications improved guideline-directed medical therapy use at 6 months for patients with diabetes at high CV or renal risk, researchers reported.

ATLANTA — Younger women with a diagnosis of anxiety or depression are at markedly higher risk for developing conditions that increase CVD risk, such as hypertension, hyperlipidemia and diabetes, researchers reported.

PCSK9 inhibitors are rejected by insurance providers at a higher rate compared with other guideline-indicated cardiometabolic drugs despite expanded labeling and reduced manufacturer cost, researchers reported.